Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) is attracting interest thanks to innovative primary prevention clinical trials and increased request for information by at-risk individuals. However, ethical, social, and psychological implications are paramount and genetic testing must be supported by structured genetic counseling. In Italy, practice parameters and guidelines for genetic counseling in dementia are not available
25% of all people aged 55 years and older have a family history of dementia. For most, the family hi...
Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a late-onset, autosomal dominant dise...
Techniques for clinical genetic testing in dementia disorders have advanced rapidly but remain to be...
Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) is...
Background: Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degenerati...
Background: A consensus protocol for genetic counselling and testing of familial dementia, the Itali...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
OBJECTIVE: When a genetic cause is suspected in a person with dementia, it creates unique diagnostic...
Alzheimer’s disease (AD) is the most common cause of dementia and a major public health concern. Cur...
OBJECTIVE: Purposes of this study are: (1) to evaluate attitudes, beliefs and experiences towards de...
A large portion of frontotemporal lobar degeneration (FTLD) patients has a family history of disease...
The challenges inherent in diagnosing and treating patients with Alzheimer's disease are increasing....
25% of all people aged 55 years and older have a family history of dementia. For most, the family hi...
Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a late-onset, autosomal dominant dise...
Techniques for clinical genetic testing in dementia disorders have advanced rapidly but remain to be...
Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) is...
Background: Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degenerati...
Background: A consensus protocol for genetic counselling and testing of familial dementia, the Itali...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
OBJECTIVE: When a genetic cause is suspected in a person with dementia, it creates unique diagnostic...
Alzheimer’s disease (AD) is the most common cause of dementia and a major public health concern. Cur...
OBJECTIVE: Purposes of this study are: (1) to evaluate attitudes, beliefs and experiences towards de...
A large portion of frontotemporal lobar degeneration (FTLD) patients has a family history of disease...
The challenges inherent in diagnosing and treating patients with Alzheimer's disease are increasing....
25% of all people aged 55 years and older have a family history of dementia. For most, the family hi...
Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a late-onset, autosomal dominant dise...
Techniques for clinical genetic testing in dementia disorders have advanced rapidly but remain to be...